FDA
approval
· 2019-08-19
FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
The FDA approved Lupin Pharmaceuticals' supplemental application for a fixed-dose combination of amlodipine and valsartan.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)